GREGORY STEINMETZ: Open Payments
NPI 1043294630 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 62 payments from 16 companies in 2025. Trend: 2023 $1,168 · 2024 $1,117 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $251 |
| GlaxoSmithKline, LLC. | 9 | $156 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| PFIZER INC. | 16 | $141 |
| Aimmune Therapeutics, Inc. | 3 | $80 |
| ABBVIE INC. | 3 | $63 |
| Amgen Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
Products named: TRELEGY ELLIPTA, Ozempic, Rybelsus, ELIQUIS, FARXIGA, AIRSUPRA, ZENPEP, OTEZLA.
Industry payments across RI — which companies pay providers there.
